[log in to unmask] wrote:
> Am I the only one wo is confused? Is the Udall bill which was
> passed an authorization bill, or an appropriations bill?
> Per Jim Cordy, ll/l0, it is an authorizations bill, and must go
> through the
> appropriations process next year.
> Per B. Schirloff, ll/ll, it is an appropriations bill.
>
> Can someone explain which it is? Authorization, or appropriations?
> And how much more work will be required to actually get the dollars
> to the right places. Thanks, Dave & Lyn
Below is the version of the Udall Bill as modified and incorported
into the larger appropriations HR2264 bill as an amendment, as I
fouund it in http://thomas.loc.gov. (the version sent to the
President.) There is no appropriated amount here. However, in the
main part of the bill covering appropriations for the NIH there are
increases over last year for the various institutes.
I will later look up and post Section 409B of 42 USC 284, which this
amends, unless someone beats me to it.
Phil Tompkins
59/8
H.R.2264
Departments of Labor, Health and Human Services, and Education, and
Related Agencies Appropriations Act, 1998 (Enrolled Bill (Sent to
President))
PARKINSON'S DISEASE RESEARCH
SEC. 603. (a) SHORT TITLE- This section may be cited as the
`Morris K. Udall Parkinson's Disease Research Act of 1997'.
(b) FINDING AND PURPOSE-
(1) FINDING- Congress finds that to take full advantage of
the tremendous potential for finding a cure or effective
treatment, the Federal investment in Parkinson's disease
must be expanded, as well as the coordination strengthened
among the National Institutes of Health research institutes.
(2) PURPOSE- It is the purpose of this section to provide
for the expansion and coordination of research regarding
Parkinson's disease, and to improve care and assistance for
afflicted individuals and their family caregivers.
(c) PARKINSON'S DISEASE RESEARCH- Part B of title IV of the
Public Health Service Act (42 U.S.C. 284 et seq.) is amended by
adding at the end the following:
`PARKINSON'S DISEASE
`SEC. 409B. (a) IN GENERAL- The Director of NIH shall establish a
program for the conduct and support of research and training with
respect to Parkinson's disease (subject to the extent of amounts
appropriated under subsection (e)).
`(b) INTER-INSTITUTE COORDINATION-
`(1) IN GENERAL- The Director of NIH shall provide for the
coordination of the program established under subsection (a)
among all of the national research institutes conducting
Parkinson's disease research.
`(2) CONFERENCE- Coordination under paragraph (1) shall
include the convening of a research planning conference not
less frequently than once every 2 years. Each such
conference shall prepare and submit to the Committee on
Appropriations and the Committee on Labor and Human
Resources of the Senate and the Committee on Appropriations
and the Committee on Commerce of the House of
Representatives a report concerning the conference.
`(c) MORRIS K. UDALL RESEARCH CENTERS-
`(1) IN GENERAL- The Director of NIH is authorized to award
Core Center Grants to encourage the development of
innovative multidisciplinary research and provide training
concerning Parkinson's disease. The Director is authorized
to award not more than 10 Core Center Grants and designate
each center funded under such grants as a Morris K. Udall
Center for Research on Parkinson's Disease.
`(2) REQUIREMENTS-
`(A) IN GENERAL- With respect to Parkinson's disease,
each center assisted under this subsection shall--
`(i) use the facilities of a single institution or
a consortium of cooperating institutions, and meet
such qualifications as may be prescribed by the
Director of the NIH; and
`(ii) conduct basic and clinical research.
`(B) DISCRETIONARY REQUIREMENTS- With respect to
Parkinson's disease, each center assisted under this
subsection may--
`(i) conduct training programs for scientists and
health professionals;
`(ii) conduct programs to provide information and
continuing education to health professionals;
`(iii) conduct programs for the dissemination of
information to the public;
`(iv) separately or in collaboration with other
centers, establish a nationwide data system
derived from patient populations with Parkinson's
disease, and where possible, comparing relevant
data involving general populations;
`(v) separately or in collaboration with other
centers, establish a Parkinson's Disease
Information Clearinghouse to facilitate and
enhance knowledge and understanding of Parkinson's
disease; and
`(vi) separately or in collaboration with other
centers, establish a national education program
that fosters a national focus on Parkinson's
disease and the care of those with Parkinson's
disease.
